Zobrazeno 1 - 10
of 244
pro vyhledávání: '"Zhi-hua Ran"'
Autor:
Zhi Hua Ran, Shu Dong Xiao
Publikováno v:
Journal of digestive diseases. 17(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e7c45c65bd7f90e9ee16f0f5ad7f30f
https://pubmed.ncbi.nlm.nih.gov/25688914
https://pubmed.ncbi.nlm.nih.gov/25688914
Publikováno v:
Intestinal Research, Vol 21, Iss 3, Pp 328-338 (2023)
Background/Aims Inflammatory bowel disease (IBD) is no longer a rare disease in Asia, thus it needs to prepare recommendations relevant to Asian patients. This study aimed to identify disparities in the process of the diagnosis of IBD in Asian countr
Externí odkaz:
https://doaj.org/article/ad6d630e16e4437c82e5276276ae043d
Publikováno v:
Journal of digestive diseases [J Dig Dis] 2016 Apr; Vol. 17 (4), pp. 278.
Autor:
Khoon Lin Ling, Ida Hilmi, Raja Affendi Raja Ali, Rupert W L Leong, Wai Keung Leung, Siew Chien Ng, Kai Chun Wu, Min Hu Chen, Zhi Hua Ran, Tadakazu Hisamatsu, Vineet Ahuja, Govind K Makharia, Rupa Banerjee, Shu Chen Wei, Deng Chyang Wu, Pises Pisespongsa, Byong Duk Ye, Jose Sollano, Marcellus Simadibrata, Sai Wei Chuah, Choon Jin Ooi
Publikováno v:
JGH Open, Vol 4, Iss 3, Pp 320-323 (2020)
Abstract The COVID‐19 pandemic, secondary to SARS‐CoV‐2, has resulted in high mortality and morbidity worldwide. As inflammatory bowel disease (IBD) is a chronic disease, and most patients are on long‐term immunosuppressive agents, there is u
Externí odkaz:
https://doaj.org/article/7ddcf737962b46eeb2202a0476425e87
Autor:
Yun Cui, Shi-yuan Lu, Jie Xu, Yan-shen Peng, Qi Miao, Xiao-qing Wang, Xiao-yu Chen, Zhi-hua Ran
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Double-balloon enteroscopy enables performing numerous small bowel biopsies for pathologic analysis. However, most histopathological characteristics of Crohn’s disease are non-specific characteristics. We aimed to explore the sm
Externí odkaz:
https://doaj.org/article/532607b9bdab4efca19c1cb9dedce798
Autor:
Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chian Lim, Wai Keung Leung, Raja Affendi Raja Ali, Deng Chyang Wu, Evan Ong, Nazri Mustaffa, Julajak Limsrivilai, Tadakazu Hisamatsu, Suk Kyun Yang, Qin Ouyang, Richard Geary, Janaka H De Silva, Rungsun Rerknimitr, Marcellus Simadibrata, Murdani Abdullah, Rupert WL Leong
Publikováno v:
Intestinal Research, Vol 17, Iss 3, Pp 285-310 (2019)
The Asia-Pacific Working Group on inflammatory bowel disease (IBD) was established in Cebu, Philippines, under the auspices of the Asian Pacific Association of Gastroenterology with the goal of improving IBD care in Asia. This consensus is carried ou
Externí odkaz:
https://doaj.org/article/4f1f187cd77d480a8913d3e1d6d0c1fc
Autor:
Dong Juan Song, Jun Shen, Min Hu Chen, Zhan Ju Liu, Qian Cao, Pin Jin Hu, Xiang Gao, Jia Ming Qian, Kai Chun Wu, Li Jie Lai, Zhi Hua Ran
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background and Aim: Serum immunoglobulins were reported to be associated with clinical characteristics of inflammatory bowel disease. However, whether a difference exists in the serum immunoglobulins levels in patients with Crohn's disease (CD) with
Externí odkaz:
https://doaj.org/article/a05d4313f5cb41b2802643baf68cf5ba
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248427 (2021)
Background & aimsHelicobacter pylori (H. pylori) infection remains high in China though the incidence of inflammatory bowel disease (IBD) has increased. Our aim was to investigate the relationship between the prevalence of H. pylori and inflammatory
Externí odkaz:
https://doaj.org/article/9e52870286f84953a719a206d15b1548
Autor:
Xiao-Xian Qian, Chen-Wen Cai, Han-Yang Li, Li-Jie Lai, Dong-Juan Song, Yu-Qi Qiao, Jun Shen, Zhi-Hua Ran
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 12 (2019)
Objectives: Transcribed ultraconserved region (T-UCR) uc.261 is reported to participate in intestinal mucosa barrier damage in Crohn’s disease (CD). The aim of this study was to determine the association with disease activity and intestinal permeab
Externí odkaz:
https://doaj.org/article/84d8e78577f64f70aac7ef921d17915d
Autor:
Kai-Chun Wu, Zhi Hua Ran, Xiang Gao, Minhu Chen, Jie Zhong, Jian-Qiu Sheng, Michael A Kamm, Simon Travis, Kori Wallace, Nael M Mostafa, Marisa Shapiro, Yao Li, Roopal B Thakkar, Anne M Robinson
Publikováno v:
Intestinal Research, Vol 14, Iss 2, Pp 152-163 (2016)
Background/AimsThis was a Phase 2 study (NCT02015793) to evaluate the pharmacokinetics, safety, and efficacy of adalimumab in Chinese patients with Crohn's disease (CD).MethodsThirty, adult Chinese patients with CD (CD Activity Index [CDAI] 220–450
Externí odkaz:
https://doaj.org/article/8bca98f05c004c12a083df89bf50d6f6